CBC Pharma IPO Details
CBC Pharma IPO description – CBC Pharma is engaged in the business of marketing pharmaceutical critical care & health care products. It has obtained necessary approvals from FDA for getting the formulations manufactured from contract manufacturers on Loan license or on principle to principle basis.
At present, it has a wide range of products portfolio of pharmaceutical formulation including IV & IM range injections, few tablets to cater the domestic & export markets. The company has established presence in major therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology etc. It is also engaged in promoting and marketing of Active Pharmaceuticals Ingredients (API’s) in India.
Its core strength lies in marketing & also getting its approved formulation manufactured through Contract Manufacturers and marketing of therapeutic formulations under its own brand and trading of various API’s, which it commercializes through marketing network across geographies and by developing relationships with pharmaceutical companies of different sizes.
Promoters of CBC Pharma – Mr Hemant Chandravadan Bhagat and Mr Pranav Hemant Bhagat
CBC Pharma IPO details | |
Subscription Dates | 31 January – 6 February 2020 |
Price Band | INR51 per share |
Fresh issue | 2,000,000 shares (INR10.2 crore) |
Offer For Sale | Nil |
Total IPO size | 2,000,000 shares (INR10.2 crore) |
Minimum bid (lot size) | 2,000 shares |
Face Value | INR10 per share |
Retail Allocation | 50% |
Listing On | BSE SME platform |
CBC Pharma’s financial performance (in INR lakh) |
||||
 | FY2017 | FY2018 | FY2019 | 4M FY2020 |
Revenue | 9,028.1 | 9,773.4 | 10,671.8 | 3,344.5 |
Expenses | 8,936.8 | 9,620.2 | 10,583.3 | 3,311.5 |
Net income | 66.0 | 103.4 | 62.6 | 24.9 |
 |  |  |  |  |
Registrar of CBC Pharma
Link Intime India Private Limited
C-101, 1st Floor, 247 Park
Lal Bahadur Shastri Marg, Vikhroli (West)
Mumbai – 400 083
Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: [email protected]
Website: http://www.linkintime.co.in
Valuation of CBC Pharma IPO (FY2019)
Earnings Per Share (EPS): INR1.17
Price/Earnings (PE ratio): 43.59
Return on Net Worth (RONW): 4.71%
Net Asset Value (NAV): INR25.22 per share (as of 31 July 2019)
CBC Pharma IPO Subscription Details
Day |
Subscription (no. of times) |
Day 1 |
0.72 |
Day 2 |
0.83 |
Day 3 |
0.92 |
Day 4 | 1.01 |
Day 5 |
1.57 |
CBC Pharma Contact Details
Chandra Bhagat Pharma Limited
323-F Bhagat Bhuvan
Dr. Ambedkar Road, Matunga (East) Mumbai- 400019
Phone: +91 22 2414 6154
Email: [email protected]
Website:Â www.cbcpharma.com
CBC Pharma IPO Allotment Status
CBC Pharma IPO allotment status is now available on Link Intime’s website. Click on this link to get allotment status.
Listing Performance of CBC Pharma
IPO Opening Date: 31 January 2020
IPO Closing Date: 6 February 2020
Finalisation of Basis of Allotment: 11 February 2020
Initiation of refunds: 13 February 2020
Transfer of shares to demat accounts: 13 February 2020
Listing Date: 14 February 2020
Opening Price on BSE SME: INR51.7 per share (up 1.37% from IPO price)
Closing Price on BSE SME: INR51.75 per share (up 1.47% from IPO price)
Comments can be given after watching for some time